To evaluate the variation in parameters of hepatic function and in the scores Fatty Liver Index (FLI; predictor of hepatic steatosis) and BARD (BMI, AST/ALT ratio and DM, predictor of hepatic fibrosis), 1 year after bariatric surgery.
Material and Methods
This is a observational retrospective cohort study in patients with morbid obesity that underwent bariatric surgery in our centre. We used two linear regression models: (1) unadjusted and (2) adjusted for surgery type, sex, age, body mass index, diabetes, and dyslipidaemia.
The included population (n = 1955) had an average age of 43.1 ± 10 years and 85.8% were female. Diabetes was present in 32.4% of the patients, 45.1% had dyslipidaemia, and 62.2% had hypertension. Twelve percent were submitted to gastric band, 29.6% to sleeve gastrectomy, and 58.4% to gastric bypass. We observed a relevant decrease in transaminases and gamma-glutamyltransferase, and an increase in alkaline phosphatase and total bilirubin. Both FLI and BARD markedly decrease 1 year after surgery (p < 0.01). Comparing the surgical procedures, sleeve gastrectomy was associated with a greater reduction of hepatic enzymes and of both FLI and BARD compared with gastric band. Comparing with gastric bypass, sleeve was associated with a greater reduction of transaminases and alkaline phosphatase, but a smaller reduction of FLI and BARD.
Bariatric surgery is associated with a reduction of the hepatic enzymes and an improvement of FLI and BARD. It may represent an effective therapeutic approach for NAFLD.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Cheah MC, McCullough AJ, Goh GB. Current modalities of fibrosis assessment in non-alcoholic fatty liver disease. J Clin Transl Hepatol. 2017;5(3):261–71. Epub 2017/09/25. https://doi.org/10.14218/JCTH.2017.00009.
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57. Epub 2017/07/18. https://doi.org/10.1002/hep.29367.
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. Epub 2015/12/29. https://doi.org/10.1002/hep.28431.
Milic S, Lulic D, Stimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20(28):9330–7. Epub 2014/07/30. https://doi.org/10.3748/wjg.v20.i28.9330.
European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–402. Epub 2016/04/12. https://doi.org/10.1016/j.jhep.2015.11.004.
Cazzo E, Pareja JC, Chaim EA. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Med J. 2017;135(3):277–95. Epub 2017/06/01. https://doi.org/10.1590/1516-3180.2016.0306311216.
Luo RB, Suzuki T, Hooker JC, et al. How bariatric surgery affects liver volume and fat density in NAFLD patients. Surg Endosc. 2018;32(4):1675–82. Epub 2017/12/09. https://doi.org/10.1007/s00464-017-5846-9.
Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wroblewska B, et al. Liver function in patients with nonalcoholic fatty liver disease randomized to roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg. 2017;266(5):738–45. Epub 2017/08/03. https://doi.org/10.1097/SLA.0000000000002397.
Caiazzo R, Lassailly G, Leteurtre E, et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 2014;260(5):893–8; discussion 8-9. Epub 2014/11/08. https://doi.org/10.1097/SLA.0000000000000945.
Patel JJ, Mundi MS, Hurt RT, et al. Micronutrient deficiencies after bariatric surgery: an emphasis on vitamins and trace minerals [formula: see text]. Nutr Clin Pract. 2017;32(4):471–80. Epub 2017/06/14. https://doi.org/10.1177/0884533617712226.
American DA. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–28. Epub 2018/12/19. https://doi.org/10.2337/dc19-S002.
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. Epub 2018/08/31. https://doi.org/10.1093/eurheartj/ehy339.
Expert Panel on Detection E, Treatment of high blood cholesterol in A. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–97. Epub 2001/05/23. https://doi.org/10.1001/jama.285.19.2486.
Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. Epub 2006/11/04. https://doi.org/10.1186/1471-230X-6-33.
de Abreu MR, Ramos AP, Vendramini RC, et al. Steatosis and hepatic markers before and shortly after bariatric surgery. Ann Clin Biochem. 2007;44(Pt 1):63–9. Epub 2007/02/03. https://doi.org/10.1258/000456307779596002.
Sierzantowicz R, Lewko J, Trochimowicz L, et al. The effect of bariatric procedures on selected laboratory parameters of patients from rural areas in Poland. Adv Clin Exp Med. 2017;26(4):679–86. Epub 2017/07/12. https://doi.org/10.17219/acem/67150.
Hannah Jr WN, Harrison SA. Effect of weight loss, diet, exercise, and bariatric surgery on nonalcoholic fatty liver disease. Clin Liver Dis. 2016;20(2):339–50. Epub 2016/04/12. https://doi.org/10.1016/j.cld.2015.10.008.
Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532–40. Epub 2009/05/05. https://doi.org/10.1053/j.gastro.2009.04.052.
Chiappetta S, Schaack HM, Wolnerhannsen B, et al. The impact of obesity and metabolic surgery on chronic inflammation. Obes Surg. 2018;28(10):3028–40. Epub 2018/06/08. https://doi.org/10.1007/s11695-018-3320-y.
Melo TL, Froeder L, Baia LDC, et al. Bone turnover after bariatric surgery. Arch Endocrinol Metab. 2017;61(4):332–6. Epub 2017/07/21. https://doi.org/10.1590/2359-3997000000279.
Ivaska KK, Huovinen V, Soinio M, et al. Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy. Bone. 2017;95:47–54. Epub 2016/11/08. https://doi.org/10.1016/j.bone.2016.11.001.
Bawahab MA, Assiri AS, Maksoud WA, et al. Effects of weight reduction after sleeve gastrectomy on metabolic variables in Saudi obese subjects in Aseer Province of Kingdom of Saudi Arabia. Obes Surg. 2017;27(8):2005–14. Epub 2017/02/23. https://doi.org/10.1007/s11695-017-2579-8.
Jorgensen ME, Torp-Pedersen C, Finer N, et al. Association between serum bilirubin and cardiovascular disease in an overweight high risk population from the SCOUT trial. Nutr Metab Cardiovasc Dis. 2014;24(6):656–62. Epub 2014/02/19. https://doi.org/10.1016/j.numecd.2013.12.009.
Li JF, Lai DD, Lin ZH, et al. Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials. Surg Laparosc Endosc Percutan Tech. 2014;24(1):1–11. Epub 2014/02/04. https://doi.org/10.1097/SLE.0000000000000041.
Wang FG, Yu ZP, Yan WM, et al. Comparison of safety and effectiveness between laparoscopic mini-gastric bypass and laparoscopic sleeve gastrectomy: a meta-analysis and systematic review. Medicine (Baltimore). 2017;96(50):e8924. Epub 2018/02/03. https://doi.org/10.1097/MD.0000000000008924.
Aguilar-Olivos NE, Almeda-Valdes P, Aguilar-Salinas CA, et al. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. Metab Clin Exp. 2016;65(8):1196–207. Epub 2015/10/06. https://doi.org/10.1016/j.metabol.2015.09.004.
Kaplowitz N. Drug-induced liver injury. Clin Infect Dis. 2004;38(Suppl 2):S44–8. Epub 2004/02/27. https://doi.org/10.1086/381446.
Purkins L, Love ER, Eve MD, et al. The influence of diet upon liver function tests and serum lipids in healthy male volunteers resident in a phase I unit. Br J Clin Pharmacol. 2004;57(2):199–208. Epub 2004/01/30. https://doi.org/10.1046/j.1365-2125.2003.01969.x.
Conflict of Interest
The authors declare that they have no conflict of interest.
For this type of study formal consent is not required.
Informed consent does not apply.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
About this article
Cite this article
Borges-Canha, M., Neves, J.S., Mendonça, F. et al. The Impact of Bariatric Surgery on Hepatic Function and Predictors of Liver Steatosis and Fibrosis. OBES SURG 30, 2935–2941 (2020). https://doi.org/10.1007/s11695-020-04622-0
- Bariatric surgery